CaRi-Heart® Analysis Service

Caristo provides state of the art cardiac risk evaluation based on the analysis of standard CCTA scans, incorporating a personalized assessment of coronary inflammation, to help clinicians make more informed patient management decisions.

Can be applied to any routine clinical CCTA.

Analysis is performed using our patented, regulatory cleared platform, CaRi-Heart®.

Clinically demonstrated to improve discrimination of cardiac mortality prognosis over current risk assessment methods.

Interested in using CaRi-Heart® Analysis?

Get in touch for more information